Skip to main content
GNPX logo

GNPX · Genprex, Inc.

$7.67 -0.33 (-4.13%) At close · Jul 17
Market Cap
$81.20M
Shares
10,586,402

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Ryan M. Confer $728,871
Mark S. Berger $688,604
Fiscal 2024
Executive Total
Mark S. Berger $551,715
Ryan M. Confer $541,567
Catherine M. Vaczy $449,129
J. Rodney Varner $254,739
Fiscal 2023
Executive Total
J. Rodney Varner $1,680,958
Mark S. Berger $947,107
Catherine M. Vaczy $933,278
Ryan M. Confer $886,683
Fiscal 2022
Executive Total
J. Rodney Varner $2,532,400
Catherine M. Vaczy $1,208,360
Ryan M. Confer $1,135,942
Mark S. Berger $870,735
Fiscal 2021
Executive Total
J. Rodney Varner $2,347,011
Ryan M. Confer $1,339,976
Michael T. Redman $1,312,178
Catherine M. Vaczy $1,293,161
Fiscal 2020
Executive Total
J. Rodney Varner $2,113,891
Catherine M. Vaczy $1,292,631
Ryan M. Confer $1,216,859
Michael T. Redman $1,114,916
Key facts CIK 1595248 CUSIP 372446302 13F (30d) 2 filings 2 filers Visit website Investor relations